-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Lineage Cell Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2023 to Q4 2024.
- Lineage Cell Therapeutics, Inc. Costs and Expenses for the quarter ending December 31, 2024 was $7.98M, a 5.59% decline year-over-year.
- Lineage Cell Therapeutics, Inc. Costs and Expenses for the twelve months ending December 31, 2024 was $31M, a 8.02% decline year-over-year.
- Lineage Cell Therapeutics, Inc. annual Costs and Expenses for 2024 was $31M, a 8.02% decline from 2023.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)